Apexigen
A biopharmaceutical company developing antibodies for cancer, inflammatory diseases and ophthalmic diseases
4
Funding Rounds
$286.0m
Money raised
Overview
A biopharmaceutical company developing antibodies for cancer, inflammatory diseases and ophthalmic diseases
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Da* Za******* | - | - | linkedin twitter twitter instagram |
Funding
Funding series
Funding Series Analysis
The company Apexigen has raised a total of $143m in funding over 4 rounds.
Key Insights:
- Apexigen Funding Round 2020: $123m
- Apexigen Series A round: $20m
- Apexigen, Inc. funding round, December 2019: $70m
- Apexigen Inc funding round, August 2018: $73m
Apexigen Funding Round 2020
$123m
Apexigen Series A round
$20m
Apexigen, Inc. funding round, December 2019
$70m
Apexigen Inc funding round, August 2018
$73m
Industries
Apexigen is active in the following industries:
- Internal medicine
- Medicine
- Oncology
- Engineering
- Biomedical engineering
- Biopharmaceutical
- Cancer
- Diagnosis
- Pharmaceutical industry
- Technology
- Biology
- Biotechnology
- Healthcare